SCHEMBL25069751

SCHEMBL25069751

CCn1cc(C(=O)OC)c(=O)c2c(NCc3ccccc3)c(F)c(F)cc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 1/20 0.46
LMNA P02545 6/20 0.43
BRD4 O60885 1/20 0.42
PDE10A Q9Y233 1/20 0.41
HPGD P15428 6/20 0.39
ALDH1A1 P00352 5/20 0.39
KDM4E B2RXH2 5/20 0.39
TSHR P16473 2/20 0.39
RAB9A P51151 1/20 0.39
HSD17B10 Q99714 1/20 0.39
MAPT P10636 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
POLB P06746 1/20 0.39
TAAR1 Q96RJ0 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
MAPK1 P28482 1/20 0.39
GAA P10253 1/20 0.39
HTT P42858 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
PDE4A P27815 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1243138 0.93 LMNA (0.46) LMNAHPGDALDH1A1KDM4ETSHR
SCHEMBL25069320 0.86 ALDH1A1 (0.44) LMNAHPGDALDH1A1KDM4ETSHR
SCHEMBL1344978 0.85 TSHR (0.44) LMNAHPGDALDH1A1KDM4ETSHR
SCHEMBL25069794 0.85 ALDH1A1 (0.43) LMNAHPGDALDH1A1KDM4ETSHR
SCHEMBL25069770 0.82 ALDH1A1 (0.46) LMNAHPGDALDH1A1KDM4ETSHR
SCHEMBL25069650 0.80 ALDH1A1 (0.44) LMNAHPGDALDH1A1KDM4ETSHR
SCHEMBL9502058 0.79 ADRB2 (0.48) LMNAHPGDALDH1A1KDM4ERAB9A
SCHEMBL25069563 0.78 LMNA (0.46) LMNAHPGDALDH1A1KDM4ETSHR
SCHEMBL8231492 0.78 ALDH1A1 (0.37) LMNAHPGDALDH1A1KDM4ERAB9A
SCHEMBL25069608 0.77 TDP1 (0.47) LMNAHPGDALDH1A1KDM4ETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230058189-A1 QUINOLIN-4-ONE AND 4(1H)-CINNOLINONE COMPOUNDS AND METHODS OF USING SAME Frequency Therapeutics, Inc. (US) 2023-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230058189-A1 QUINOLIN-4-ONE AND 4(1H)-CINNOLINONE COMPOUNDS AND METHODS OF USING SAME DCX, NES, MCL1 NR4A2 1684/4885LMNA 2581/4885BRD4 411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.